# Abaloparatide — dosage, half-life & reference guide

Source: https://pepvault.app/peptides/abaloparatide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Healing & recovery](https://pepvault.app/peptides#healing)

# Abaloparatide Dosage, half-life & reference guide

Also known as Tymlos · BA058

Reviewed November 2026 8 studies Evidence: Established [Published by PepVault](https://pepvault.app/guides/how-we-research)

A daily shot (Tymlos) that builds new bone, a close relative of teriparatide modelled on a different natural hormone, PTHrP. In its 18-month trial, new spine fractures fell from 4.2% on placebo to 0.6%, and blood calcium ran high less often than on teriparatide.

- **FDA label:** 80 mcg starting dose 80 mcg
- **How often:** Daily
- **Half-life:** ~1 hour
- **Evidence:** Established
- **Route:** SubQ injection

[Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

## How it works.

A bone-building 34-amino-acid peptide modelled on PTHrP, the parathyroid-hormone-related peptide (76% the same as its active part, 41% the same as teriparatide's PTH). It activates the PTH1 receptor on bone cells, and a daily dose stimulates the bone-building cells, so new bone forms on the inner and outer surfaces. FDA-approved in 2017 for postmenopausal women with osteoporosis at high fracture risk, and later for men; it is the sibling of teriparatide, with one dose and the same 2-year limit.

**Commonly reported:** Redness where the shot goes in, and dizziness or a fast heartbeat for a while after the first doses. FDA-approved since 2017, for up to 2 years.

### Half-life & active level

The half-life of Abaloparatide is ~1 hour (FDA label).

Here's how a typical Abaloparatide schedule plays out over 48 hours (one-compartment estimate).

An estimate from the half-life above, not a measurement. See your own curve build live in [the half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator).

<!--promo-->

PepVault for iPhone

## Track abaloparatide in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where Abaloparatide works.

- ### Joints & tendons

  **In people.** In its 18-month trial, new spine fractures fell from 4.2% on placebo to 0.6%, and blood calcium ran high less often than on teriparatide.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

## Week by week.

What to expect in the first 8 weeks

- **Onset:** 1 month (bone formation markers)
- **Peak effect:** 12–18 months (BMD, fracture risk)
- **Duration:** Up to 24 months

1. Day 1–14 · 80 mcg RCT

   ### The first shots, sitting down

   Abaloparatide has one dose, 80 mcg a day, with no ramp. The label gives the first several shots sitting or lying down: a fast heartbeat or dizziness can come within a few hours and usually settles by lying down.

   The science

   Orthostatic hypotension can occur, typically within 4 hours of injection, with dizziness, palpitations, tachycardia or nausea (Tymlos label §5.3). In its thorough QT study, heart rate rose a mean 15 bpm at 15 minutes after 80 mcg, and the increase resolved in about 6 hours. Dizziness: 10% vs 6% on placebo; palpitations 5% vs 0.4%.

   Sources

   - FDA Tymlos label (2026)

   Updated Nov 2026
2. Day 14–60 RCT

   ### Redness where the shot goes in

   Redness at the injection spot is the most common thing people notice in the first month; rotating the spot around the navel each day is what the label describes. Severe reactions were rare in its trial.

   The science

   In the first month of the fracture trial, injection-site reactions were checked daily 1 hour after the shot: redness 58% vs 28% on placebo, swelling 11% vs 3%, pain 10% vs 7%; severe redness, swelling and pain in 2.9%, 0.4% and 0.4% (label).

   Sources

   - FDA Tymlos label (2026)

   Updated Nov 2026
3. Any day RCT

   ### What Abaloparatide is built on

   Abaloparatide was approved in 2017 on ACTIVE, an 18-month fracture trial of 2,463 women that also ran teriparatide openly beside it. High blood calcium was less common than on teriparatide; the trial was not built to compare their fracture rates.

   The science

   ACTIVE (Miller 2016) randomised women to blinded abaloparatide 80 mcg or placebo, with an open-label teriparatide 20 mcg arm; the primary end point was abaloparatide vs placebo. Hypercalcemia: 3.4% vs 6.4% on teriparatide. The men's indication rests on Study 019 (label). In rats, osteosarcoma reached 87% of high-dose males; its relevance to people is uncertain.

   Sources

   - Miller et al. (ACTIVE) (2016)
   - FDA Tymlos label (2026)

   Updated Nov 2026
4. With BPC-157 and TB-500 Community

   ### Why people pair it with BPC-157 or TB-500

   Some people with a bone injury run BPC-157 or TB-500 beside a prescribed bone-building drug, hoping the soft-tissue peptides help the tissue around it. Commonly reported as a pairing; no trial has tested it.

   The science

   Abaloparatide's bone effect is shown in people (Miller 2016); BPC-157's repair research is almost all in animals (Sikiric 2018). No study has combined them.

   Sources

   - Miller et al. (ACTIVE) (2016)
   - Sikiric et al. (2018)

   Updated Nov 2026

### After week 8

1. Day 60–365 RCT

   ### New bone, built in the background

   There's little to feel while it works; the change shows on a bone scan. In its men's trial, spine density rose 8.5% in a year, against 1.2% on placebo.

   The science

   Bone formation marker sPINP peaked at month 1 (93% above baseline in women, 133% in men) and stayed raised (label). In Study 019 (228 men, 12 months), lumbar spine BMD rose 8.5% vs 1.2% on placebo, total hip 2.1% vs under 0.1%, and femoral neck 3.0% vs 0.2%.

   Sources

   - FDA Tymlos label (2026)

   Updated Nov 2026
2. Day 365–730 RCT

   ### Fewer fractures, then the 2-year line

   In its fracture trial new spine fractures fell by 86% over 18 months. The label doesn't recommend more than 2 years in a lifetime; in the trial, alendronate afterwards kept the lower risk.

   The science

   ACTIVE (Miller 2016): new vertebral fractures 0.6% vs 4.2% on placebo at 18 months (relative risk reduction 86%); nonvertebral fractures 2.7% vs 4.7% (43%). After 18 months, patients moved to alendronate: at 25 months vertebral fractures were 0.6% vs 4.4%, and the reduction held through 24 months of alendronate (label).

   Sources

   - Miller et al. (ACTIVE) (2016)
   - FDA Tymlos label (2026)

   Updated Nov 2026

Day 1 is the day you start it.

FDA Tymlos label (DailyMed, effective August 2026); ACTIVE (Miller 2016). Approved for osteoporosis at high fracture risk in postmenopausal women and men.

Clinical trial data

## More on abaloparatide

### Dose Guide

- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)

## A typical run.

### Run notes

- **Cycle:** The label does not recommend more than 2 years in a lifetime; its fracture trial ran 18 months, followed in the trial by alendronate, which kept the lower fracture risk through 24 more months. Community practice — opinions vary. Not a clinical recommendation.
- **Timing:** Once daily at about the same time, into the abdomen around the navel, rotating the spot each day; the first several doses sitting or lying down (label). Levels peak about 30 minutes after a shot. The pen is refrigerated until first use, then kept at room temperature for up to 30 days.
- **Route:** SubQ injection
- **Stacks:** BPC-157, TB-500

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-mixing&mt=8)

<!--/promo-->

## Safety.

### Common side effects

- Injection site redness
- Dizziness
- Nausea
- Headache
- Palpitations
- Fatigue
- High urine calcium

#### Interactions

No drug-interaction studies have been done (label). Calcium and vitamin D are added if the diet falls short. No trial has combined it with teriparatide; both act on the same receptor, and each label limits use to about 2 years in a lifetime. Discuss all your medicines with your clinician.

### Safety notes

The current Tymlos label has no boxed warning. In a 2-year rat study, osteosarcoma rose with dose at every dose tested (up to 87% of males and 62% of females at the highest, against 0-2% of controls); whether it does so in people is unknown, observational studies of PTH analogs have not shown a raised risk, and data beyond 2 years are limited. The label avoids it in anyone with a raised baseline risk: growing bones, Paget's disease or another bone disease, bone cancer or metastases, or radiation to the skeleton. A drop in blood pressure on standing can come within 4 hours of a shot, with dizziness, a racing heart or nausea, so the first doses are given sitting or lying down; heart rate rose 15 beats per minute on average shortly after a dose and settled within about 6 hours. It can raise blood and urine calcium, so it is not used with a high-calcium disorder. Serious allergic reactions have been reported. These are label findings; review them with your clinician.

## Goes with.

- [BPC-157](https://pepvault.app/peptides/bpc-157)
- [TB-500](https://pepvault.app/peptides/tb-500)

## One question at a time.

- [Half-life](https://pepvault.app/peptides/abaloparatide/half-life)
- [Side effects](https://pepvault.app/peptides/abaloparatide/side-effects)
- [How long it takes to work](https://pepvault.app/peptides/abaloparatide/how-long-to-work)
- [Legal status](https://pepvault.app/peptides/abaloparatide/legal-status)

## Brand-name products.

- [Tymlos](https://pepvault.app/drugs/tymlos)

## Compared with.

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

## Studies, in plain English.

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023)
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018)
- [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017)
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

## Questions people ask.

### What is Abaloparatide?

A daily shot (Tymlos) that builds new bone, a close relative of teriparatide modelled on a different natural hormone, PTHrP. In its 18-month trial, new spine fractures fell from 4.2% on placebo to 0.6%, and blood calcium ran high less often than on teriparatide.

### How is Abaloparatide dosed in research?

The FDA label range for Abaloparatide is 80 mcg, daily SubQ, with a 80 mcg starting dose.

### How long does Abaloparatide last?

The half-life of Abaloparatide is ~1 hour (FDA label).

### What do people report on Abaloparatide?

Commonly reported on Abaloparatide: redness where the shot goes in, and dizziness or a fast heartbeat for a while after the first doses. FDA-approved since 2017, for up to 2 years.

### Is Abaloparatide safe?

The research basis for Abaloparatide is established: clinical trials or FDA-approved use exists. Common side effects in the library: injection site redness, dizziness, nausea, headache, palpitations, fatigue and high urine calcium.

### What does Abaloparatide stack with?

Common stacks for Abaloparatide: BPC-157 and TB-500.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-next-questions&mt=8)

<!--/promo-->

## Research.

The literature

### Search the latest research

[PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=Abaloparatide) [Google Scholar](https://scholar.google.com/scholar?q=Abaloparatide)

## Reference.

- **Cadence:** Daily Daily SubQ
- **Half-life:** ~1 hour ~1 hour (FDA label)
- **Research basis:** Established Clinical trials or FDA-approved use exists

## More healing & recovery peptides

- [Ac-SDKP 250–750 mcg](https://pepvault.app/peptides/tb-500-fragment)
- [GHK-Cu 1–2 mg](https://pepvault.app/peptides/ghk-cu)
- [KPV 100–300 mcg](https://pepvault.app/peptides/kpv)
- [AOD-9604 250–300 mcg](https://pepvault.app/peptides/aod-9604)
- [Thymosin Alpha-1 1–1.6 mg](https://pepvault.app/peptides/thymosin-alpha-1)
- [Thymalin No reference dose](https://pepvault.app/peptides/thymalin)

## Free tools

- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Track abaloparatide in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track abaloparatide in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on abaloparatide

### Dose Guide

- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Stack](https://pepvault.app/glossary/stack)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)

<!--promo-->

PepVault for iPhone

## Track abaloparatide in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
